Zongertinib in HER2-Mutant Advanced/Metastatic Solid Tumors: A Narrative Review and Future Prospectives
Human epidermal growth factor receptor 2 (HER2) has emerged as a critical therapeutic target in various malignancies, most notably breast and gastric cancers. While significant advances have been made in treating HER2-amplified tumors, therapeutic options for tumors harboring activating HER2 mutati...
محفوظ في:
| المؤلفون الرئيسيون: | , , , , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
ETERNO PRESS SDN. BHD.
2026-04-01
|
| سلاسل: | Journal of Cancer Biomoleculars and Therapeutics |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://jcbt.eternopublisher.com/index.php/jcbt/article/view/99 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|